C115H134N30O6 — CID 159255053
[6-[6-(cyclopentylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[6-[[(2S)-3,3-dimethylbutan-2-yl]amino]-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)butyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (PubChem CID 159255053) has the molecular formula C115H134N30O6 and a molecular weight of 2032.54 g/mol. Its IUPAC name is [6-[6-(cyclopentylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[6-[[(2S)-3,3-dimethylbutan-2-yl]amino]-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)butyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.
| Compound Name | [6-[6-(cyclopentylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[6-[[(2S)-3,3-dimethylbutan-2-yl]amino]-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)butyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol |
|---|---|
| PubChem CID | 159255053 |
| Molecular Formula | C115H134N30O6 |
| Molecular Weight | 2032.54 g/mol |
| Exact Mass | 2031.11 |
| IUPAC Name | [6-[6-(cyclopentylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[6-[[(2S)-3,3-dimethylbutan-2-yl]amino]-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)butyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol |
| SMILES | CCC[C@H](Nc1nnc(-c2ccc(-n3cnc(C)c3)c(CO)n2)cc1C)c1ccc(C)cc1.Cc1ccc([C@@H](CO)Nc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C)cc1.Cc1ccc([C@H](C)Nc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C)cc1.Cc1cn(-c2ccc(-c3cc(C)c(NC4CCCC4)nn3)nc2CO)cn1.Cc1cn(-c2ccc(-c3cc(C)c(N[C@@H](C)C(C)(C)C)nn3)nc2CO)cn1 |
| InChI | InChI=1S/C26H30N6O.C24H26N6O2.C24H26N6O.C21H28N6O.C20H24N6O/c1-5-6-21(20-9-7-17(2)8-10-20)29-26-18(3)13-23(30-31-26)22-11-12-25(24(15-33)28-22)32-14-19(4)27-16-32;1-15-4-6-18(7-5-15)21(12-31)27-24-16(2)10-20(28-29-24)19-8-9-23(22(13-32)26-19)30-11-17(3)25-14-30;1-15-5-7-19(8-6-15)18(4)26-24-16(2)11-21(28-29-24)20-9-10-23(22(13-31)27-20)30-12-17(3)25-14-30;1-13-9-17(25-26-20(13)23-15(3)21(4,5)6)16-7-8-19(18(11-28)24-16)27-10-14(2)22-12-27;1-13-9-17(24-25-20(13)22-15-5-3-4-6-15)16-7-8-19(18(11-27)23-16)26-10-14(2)21-12-26/h7-14,16,21,33H,5-6,15H2,1-4H3,(H,29,31);4-11,14,21,31-32H,12-13H2,1-3H3,(H,27,29);5-12,14,18,31H,13H2,1-4H3,(H,26,29);7-10,12,15,28H,11H2,1-6H3,(H,23,26);7-10,12,15,27H,3-6,11H2,1-2H3,(H,22,25)/t2*21-;18-;15-;/m0100./s1 |
| InChIKey | KVUCPTHPTAPREZ-HFTZDTTISA-N |
| XLogP | 19.57 |
| TPSA | 463.98 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 151 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2032.54 |
| LogP ≤ 5 | 19.57 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 36 |